UNIVERSITY PARK, Pa. — One of the many Penn State units that adapted to the pandemic’s challenges was the Center of Excellence in Industrial Biotechnology (CoEIB).
Prior to COVID-19, the CoEIB was fostering a skilled workforce through its collaboration with the CSL Behring Fermentation Facility and the Society for Industrial Biotechnology (SIB). Also striving for excellence in research and outreach, the CoEIB offered scholarships, seed grants and internships to undergraduate students.
Over the next 450+ days, the CoEIB pushed forward, continuing to both harbor and grow Penn State’s industrial biotechnology community.
Cell culture comes to Penn State
On Jan. 21, it was announced that Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, committed $1.5 million to Penn State, creating the Sartorius Cell Culture Facility, which expanded Penn State’s biotechnology ecosystem.
After the appointments of Yuguo Lei, associate professor of biomedical engineering, as faculty director; and Randall Rossi as director, to oversee the Sartorius Cell Culture Facility, work accelerated to prepare the new space located in Chandlee Laboratory.
In early April, over 300 global spectators representing Sartorius, Penn State and biotechnology companies gathered virtually to witness the naming of the facility.
Professional workshops go virtual
To continue its mission of outreach, the CoEIB transitioned Penn State’s long history of in-person fermentation and downstream workshops to a fully virtual experience. The program’s unique approach to scheduling, concentrated sessions over sequential weeks, enabled over 150 employees from 3M, AbbVie, AstraZeneca, CSL Behring, Merck & Co., Pall Corporation, Pfizer and Scientific Bioprocessing to participate.
“We enrolled eight employees to supplement their cell culture knowledge and walked away with a team prepared to identify solutions that are customers are looking for in bioprocessing,” said James "Bucky" Polk, chief commercial officer of scientific bioprocessing.
Creating a sustainable cohort through seed grants and scholarships
The CoEIB’s IMPACT seed grant program funds interdisciplinary research, curricular development or educational activities in industrial biotechnology.
Despite being amid the early stages of the pandemic, the CoEIB funded six seed grant projects in 2020, totaling more than $110,000. With COVID-19 restrictions rapidly reducing on-campus research activities, the CoEIB extended seed grant funding through 2021 to support the primary investigators and their student research teams.
The CoEIB stepped in to provide financial relief to students, officially awarding 40 students CSL Behring Innovation and Biotechnology Scholarships in 2020 and 2021, totaling $50,000. The scholarships helped the recipients continue their biotechnology-focused education at Penn State.